stockrowNautilus Biotechnology, Inc. (NAUT) vs Ocugen, Inc. (OCGN)
- Nautilus Biotechnology, Inc. NAUT 2.23 +3.72%
- Ocugen, Inc. OCGN 0.93 +13.41%
Nautilus Biotechnology, Inc. and Ocugen, Inc. are both Biotechnology companies. Nautilus Biotechnology, Inc. and Ocugen, Inc. are of similar size ($276.9M and $273.9M). Nautilus Biotechnology, Inc. has the higher net margin (0.00% vs −1,367.6%) and the lower return on invested capital (−133.5% vs 0.00%). Across the 13 metrics below, Nautilus Biotechnology, Inc. leads on 8 and Ocugen, Inc. on 5.
Valuation
Profitability
| Metric | NAUT | OCGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 68.51% |
| Operating margin | 0.00% | (1,444.47%) | 0.00% |
| Net margin | 0.00% | (1,367.61%) | 0.00% |
| Free cash flow margin | 0.00% | (1,337.16%) | 0.00% |
| Return on equity | (41.01%) | 923.92% | (51.96%) |
| Return on assets | (33.49%) | (78.91%) | (46.06%) |
| Return on invested capital | (133.48%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack